May 05, 2020
As the nation makes its initial move to re-open some businesses and ease the economy back to pre-pandemic levels, the one thought on everyone’s minds is: when will we be back to pre-pandemic levels of normalcy? The Economist describes what a 90% economy will look and feel like.
Is there a treatment on the horizon for COVID-19? Gilead’s Remdesivir may be it. Should we be excited?
The COVID-19 crisis has exposed structural deficiencies in the most advanced, most expensive healthcare system in the world. Physician-writer Siddhartha Mukherjee provides an insider’s view in this New Yorker piece. One of the big challenges he points out is the lack of interoperability and the ill-suited nature of EHR systems to provide actionable clinical information to deal with the current crisis.
My latest podcast guest, Russ Branzell, CEO of industry organization CHIME, talks about how the final interoperability ruling announced last month could change that.
Digital transformation in healthcare: our picks for the week
The one drug that seems to have the most promising treatment for COVID-19 infections and how its commercial ease is being fast-tracked.
The coming new normal may be a muted version of the pre-pandemic era with a broad range of self and government imposed restrictions.
The author, a well-known writer on medicine, lays out a long list of litanies in this indictment of the most advanced and most expensive healthcare system in the world.
A system that was designed primarily to enable accurate billing for medical services falls short of expectations in dealing with the current pandemic.
The Hippocratic dilemmas of contact tracing technologies. Privacy is the least of it.
CIOs should leverage the current business slowdown imposed by the COVID-19 pandemic to assess the digital transformation skills of every individual on their IT staff.
Telehealth provider Teladoc’s visits increased by 41% last quarter. No surprises there. What’s next?
The latest from Damo Consulting
“The desire with the final interoperability rule is to liberate data flow in the industry.”
A review of the financial and market performance of global technology consulting firms in healthcare.
A complimentary e-book on highlights of the COVID-19 CARES Telehealth Program by FCC.
Damo Consulting CEO Paddy Padmanabhan speaks about the impact of Covid-19 on technology in healthcare.
It’s a remarkable story that is playing out in the technology-led enablement at the back end of healthcare organizations, even as the headlines are dominated by the heroic response efforts at the front lines of care.
Our latest white paper explores how health systems can accelerate digital transformation.
The WITCH Monthly Monitor (April) – Our monthly update on major global IT consulting and services firms in healthcare provides latest financial and market performance updates on WITCH companies along with other global IT consulting firms.
*WITCH Monthly Monitor is now available as free 1-year subscription with every purchase of The WITCH Report – Annual Review.